Ovarian endometriosis (Endometrioma). Noninflammatory diseases of female pelvic organs.
Conditions
Interventions
In this study ,patients undergo Sclerotherapy after the end of menstruation, in the operation room, under general anesthesia, prep and drape was performed ( vagina is washed with Povidine Idoine comp
Sponsors
Research assistant of Tehran University of medical science
Eligibility
Sex/Gender
Female
Age
18 Years to 42 Years
Inclusion criteria
Inclusion criteria: Poor responder patients to ART with endometrioma. With history of on unsuccessful ART.
Exclusion criteria
Exclusion criteria: Previous pelvic infection History of previous Poly cystic ovarian syndrome. Male factor infertility Obesity BMI>30 kg/M2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Shrinkage of endometrioma. Timepoint: It is usually measured at the end of menstruation. Method of measurement: Endometrioma is measured by the transvaginal ultrasound.;Pregnancy rate:total number of pregnancy in this study group. Timepoint: 15 days after embryo transfer. Method of measurement: BY measurement of serum beta Hcg (pregnancy test) and doing transvaginal sonography .;The number of mature oocyte (M2) that could be the sign of improve oocyte quality. Timepoint: On the day of oocyte retrieval. Method of measurement: By Electronic Microscope and under embryologist observation.;The number of embryo formation after IVF. Timepoint: 3th days after oocyte retrieval . Method of measurement: With Electronic Microscope and under embryologist observation. | — |
Secondary
| Measure | Time frame |
|---|---|
| The amount of pelvic pain included Dysmenorrhea and Dyspareunia. Timepoint: At least two month after Sclerotherapy. Method of measurement: Pain Scoring with the help of Visual Analogue scale( VAS) that measures pain intensity.;The Endometrioma Recurrence. Timepoint: 8 to 12 weeks after Sclerotherapy. Method of measurement: By Transvaginal sonography.;Intermenstrual bleeding and Abnormal uterine bleeding (AUB). Timepoint: At least 8 to 10 weeks after the procedure. Method of measurement: With the help of patients history . | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLadan Kashani
Tehran University of Medical Sciences
Outcome results
None listed